Literature DB >> 30811773

Spatial source phase: A new feature for identifying spatial differences based on complex-valued resting-state fMRI data.

Yue Qiu1, Qiu-Hua Lin1, Li-Dan Kuang2, Xiao-Feng Gong1, Fengyu Cong3,4, Yu-Ping Wang5, Vince D Calhoun6,7.   

Abstract

Spatial source phase, the phase information of spatial maps extracted from functional magnetic resonance imaging (fMRI) data by data-driven methods such as independent component analysis (ICA), has rarely been studied. While the observed phase has been shown to convey unique brain information, the role of spatial source phase in representing the intrinsic activity of the brain is yet not clear. This study explores the spatial source phase for identifying spatial differences between patients with schizophrenia (SZs) and healthy controls (HCs) using complex-valued resting-state fMRI data from 82 individuals. ICA is first applied to preprocess fMRI data, and post-ICA phase de-ambiguity and denoising are then performed. The ability of spatial source phase to characterize spatial differences is examined by the homogeneity of variance test (voxel-wise F-test) with false discovery rate correction. Resampling techniques are performed to ensure that the observations are significant and reliable. We focus on two components of interest widely used in analyzing SZs, including the default mode network (DMN) and auditory cortex. Results show that the spatial source phase exhibits more significant variance changes and higher sensitivity to the spatial differences between SZs and HCs in the anterior areas of DMN and the left auditory cortex, compared to the magnitude of spatial activations. Our findings show that the spatial source phase can potentially serve as a new brain imaging biomarker and provide a novel perspective on differences in SZs compared to HCs, consistent with but extending previous work showing increased variability in patient data.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  auditory cortex; complex-valued fMRI data; default mode network; independent component analysis; resting-state fMRI data; schizophrenia; spatial source phase

Mesh:

Year:  2019        PMID: 30811773      PMCID: PMC6865858          DOI: 10.1002/hbm.24551

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  47 in total

1.  Independent component analysis of fMRI data in the complex domain.

Authors:  V D Calhoun; T Adali; G D Pearlson; P C M van Zijl; J J Pekar
Journal:  Magn Reson Med       Date:  2002-07       Impact factor: 4.668

2.  Reduced dendritic spine density in auditory cortex of subjects with schizophrenia.

Authors:  Robert A Sweet; Ruth A Henteleff; Wei Zhang; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2008-05-07       Impact factor: 7.853

3.  Phase based venous suppression in resting-state BOLD GE-fMRI.

Authors:  Andrew T Curtis; R Matthew Hutchison; Ravi S Menon
Journal:  Neuroimage       Date:  2014-06-05       Impact factor: 6.556

4.  Aberrant "default mode" functional connectivity in schizophrenia.

Authors:  Abigail G Garrity; Godfrey D Pearlson; Kristen McKiernan; Dan Lloyd; Kent A Kiehl; Vince D Calhoun
Journal:  Am J Psychiatry       Date:  2007-03       Impact factor: 18.112

Review 5.  Neuronal networks in Alzheimer's disease.

Authors:  Yong He; Zhang Chen; Gaolang Gong; Alan Evans
Journal:  Neuroscientist       Date:  2009-05-20       Impact factor: 7.519

6.  Quality Map Thresholding for De-noising of Complex-Valued fMRI Data and Its Application to ICA of fMRI.

Authors:  Pedro A Rodriguez; Nicolle M Correa; Tom Eichele; Vince D Calhoun; Tülay Adali
Journal:  J Signal Process Syst       Date:  2009-09-01

7.  Changes in fMRI magnitude data and phase data observed in block-design and event-related tasks.

Authors:  Sunil Kumar Arja; Zhaomei Feng; Zikuan Chen; Arvind Caprihan; Kent A Kiehl; Tülay Adali; Vince D Calhoun
Journal:  Neuroimage       Date:  2009-11-10       Impact factor: 6.556

8.  Resting state and task-induced deactivation: A methodological comparison in patients with schizophrenia and healthy controls.

Authors:  Maggie V Mannell; Alexandre R Franco; Vince D Calhoun; Jose M Cañive; Robert J Thoma; Andrew R Mayer
Journal:  Hum Brain Mapp       Date:  2010-03       Impact factor: 5.038

9.  Decreased hemispheric connectivity and decreased intra- and inter- hemisphere asymmetry of resting state functional network connectivity in schizophrenia.

Authors:  O Agcaoglu; R Miller; E Damaraju; B Rashid; J Bustillo; M S Cetin; T G M Van Erp; S McEwen; A Preda; J M Ford; K O Lim; D S Manoach; D H Mathalon; S G Potkin; V D Calhoun
Journal:  Brain Imaging Behav       Date:  2018-06       Impact factor: 3.978

10.  Preserving subject variability in group fMRI analysis: performance evaluation of GICA vs. IVA.

Authors:  Andrew M Michael; Mathew Anderson; Robyn L Miller; Tülay Adalı; Vince D Calhoun
Journal:  Front Syst Neurosci       Date:  2014-06-26
View more
  4 in total

1.  Spatial source phase: A new feature for identifying spatial differences based on complex-valued resting-state fMRI data.

Authors:  Yue Qiu; Qiu-Hua Lin; Li-Dan Kuang; Xiao-Feng Gong; Fengyu Cong; Yu-Ping Wang; Vince D Calhoun
Journal:  Hum Brain Mapp       Date:  2019-02-27       Impact factor: 5.038

2.  Shift-Invariant Canonical Polyadic Decomposition of Complex-Valued Multi-Subject fMRI Data With a Phase Sparsity Constraint.

Authors:  Li-Dan Kuang; Qiu-Hua Lin; Xiao-Feng Gong; Fengyu Cong; Yu-Ping Wang; Vince D Calhoun
Journal:  IEEE Trans Med Imaging       Date:  2019-08-19       Impact factor: 10.048

3.  Phase fMRI defines brain resting-state functional hubs within central and posterior regions.

Authors:  Zikuan Chen; Ebenezer Daniel; Bihong T Chen
Journal:  Brain Struct Funct       Date:  2021-05-29       Impact factor: 3.270

4.  Adjunct ketamine treatment of depression in treatment-resistant schizophrenia patients is unsatisfactory in pilot and secondary follow-up studies.

Authors:  Chuanjun Zhuo; Xiaodong Lin; Hongjun Tian; Sha Liu; Haiman Bian; Ce Chen
Journal:  Brain Behav       Date:  2020-03-15       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.